GAITHERSBURG, Md., Oct. 30, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its third quarter 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, November 6, 2025. Details of the event and replay are as follows:
|
Conference call details: |
|
|
Date: |
November 6, 2025 |
|
Time: |
8:30 a.m. ET |
|
URL to register phone: |
|
|
Dial-in number: |
(888) 880-3330 (U.S.) or |
|
(+1) (646) 357-8766 (International) |
|
|
Webcast: |
|
Replay details: |
|
|
Date: |
Available starting at 11:30 a.m. ET, November 6, 2025, until 11:59 p.m. ET, November 13, 2025 |
|
Dial-in number: |
(800) 770-2030 (U.S.) or |
|
(+1) (609) 800-9909 (International) |
|
|
Passcode: |
3585070# |
|
Webcast: |
ir.novavax.com/events, until December 5, 2025 |
About NovavaxNovavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M® adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via research and development innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.com and LinkedIn for more information.
Contacts:
InvestorsLuis Sanay, CFA240-268-2022ir@novavax.com
MediaYvonne Sprow844-264-8571media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-report-third-quarter-2025-financial-results-on-november-6-2025-302599179.html
SOURCE Novavax, Inc.